Protocol · Cardiovascular Health
Cardiomyopathy Supportive Care Protocol
Coenzyme Q10 (CoQ10) and Omega-3 Fatty Acids are the core of this stack, with 7 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Cardiomyopathy Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
9 supplements · 2 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Coenzyme Q10 (CoQ10) | Amount listed: 200–400 mg daily in divided doses (ubiquinol form better absorbed) | Essential for mitochondrial energy production in heart muscle; deficient in heart failure; may improve cardiac function
| Grade D for Exercise Tolerance2 studies · 41 people | ||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | Anti-inflammatory and antiarrhythmic; reduces cardiac events in heart failure; guideline-recommended
| Grade D for Blood glucose42 people | ||
| Supporting stackListed as additions to the core | |||||
| L-Carnitine | Amount listed: 2–3 g daily in divided doses | Supports fatty acid transport for energy production; may improve exercise capacity and symptoms | Not graded yet | ||
| D-Ribose | Amount listed: 5 g three times daily | Sugar needed for ATP regeneration; may improve energy and exercise tolerance in heart failure | Not graded yet | ||
| Magnesium | Amount listed: 300–400 mg daily | Essential for cardiac function and rhythm; deficiency common with diuretics; supports muscle function | Not graded yet | ||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (test and correct deficiency) | Deficiency associated with worse heart failure outcomes; supports muscle function | Not graded yet | ||
| Thiamine (Vitamin B1) | Amount listed: 100 mg daily | Deficiency causes cardiomyopathy (beriberi); depleted by diuretics; supports cardiac energy metabolism | Not graded yet | ||
| Taurine | Amount listed: 2–3 g daily in divided doses | Abundant in heart; supports calcium handling and contractility; may benefit heart failure | Not graded yet | ||
| Hawthorn | Amount listed: 450–900 mg standardized extract daily | Traditional heart herb; may improve symptoms and exercise capacity; use with medical supervision | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Cardiomyopathy. If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Each opens third-party tested products, matched to the dose above where we can.
- Grade D
- Grade D
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
How this protocol works
In plain language
Cardiomyopathy refers to diseases of the heart muscle that make it harder for the heart to pump blood. Types include dilated cardiomyopathy (enlarged, weakened heart), hypertrophic cardiomyopathy (thickened heart muscle), and restrictive cardiomyopathy (stiff heart). Causes include genetics, coronary artery disease, viral infections, alcohol, and medications (like some chemotherapy drugs).
CRITICAL: Cardiomyopathy is a serious condition requiring cardiology care. This protocol is SUPPORTIVE ONLY and does not replace medical treatment.
STANDARD MEDICAL TREATMENTS include:
- ACE inhibitors/ARBs (enalapril, losartan)
- Beta-blockers (carvedilol, metoprolol)
- Diuretics for fluid management
- ARNI (sacubitril/valsartan)
- SGLT2 inhibitors (dapagliflozin, empagliflozin)
- Implantable devices (ICD, CRT)
- Heart transplant for end-stage disease
ALWAYS consult your cardiologist before starting supplements, as some may interact with heart medications.
CoQ10* is the most studied supplement for cardiomyopathy. The Q-SYMBIO trial showed reduced cardiovascular events and improved symptoms. The heart requires enormous amounts of energy, and CoQ10 is essential for cellular energy production.
Omega-3 Fatty Acids* are recommended by heart failure guidelines. The GISSI-HF trial showed reduced mortality with omega-3 supplementation.
L-Carnitine and D-Ribose* support cardiac energy metabolism.
Thiamine (B1)* deficiency can cause cardiomyopathy and is depleted by common diuretics like furosemide. Supplementation is often recommended.
Magnesium* is frequently low with diuretic use and is essential for heart rhythm.
Expected timeline: Benefits from supplements develop over weeks to months. Regular monitoring of heart function is essential.